Logo image of DIM.PA

SARTORIUS STEDIM BIOTECH (DIM.PA) Stock Fundamental Analysis

EPA:DIM - Euronext Paris - Matif - FR0013154002 - Common Stock - Currency: EUR

212.6  +1.1 (+0.52%)

Fundamental Rating

4

Taking everything into account, DIM scores 4 out of 10 in our fundamental rating. DIM was compared to 16 industry peers in the Life Sciences Tools & Services industry. DIM has an average financial health and profitability rating. While showing a medium growth rate, DIM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year DIM was profitable.
In the past year DIM had a positive cash flow from operations.
In the past 5 years DIM has always been profitable.
DIM had a positive operating cash flow in each of the past 5 years.
DIM.PA Yearly Net Income VS EBIT VS OCF VS FCFDIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 2.46%, DIM is in line with its industry, outperforming 50.00% of the companies in the same industry.
DIM has a Return On Equity (5.14%) which is comparable to the rest of the industry.
DIM's Return On Invested Capital of 4.36% is on the low side compared to the rest of the industry. DIM is outperformed by 68.75% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DIM is above the industry average of 6.90%.
The last Return On Invested Capital (4.36%) for DIM is well below the 3 year average (10.41%), which needs to be investigated, but indicates that DIM had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.46%
ROE 5.14%
ROIC 4.36%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
DIM.PA Yearly ROA, ROE, ROICDIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of DIM (7.15%) is better than 68.75% of its industry peers.
In the last couple of years the Profit Margin of DIM has declined.
With a Operating Margin value of 14.05%, DIM perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
DIM's Operating Margin has declined in the last couple of years.
DIM's Gross Margin of 43.89% is fine compared to the rest of the industry. DIM outperforms 62.50% of its industry peers.
In the last couple of years the Gross Margin of DIM has declined.
Industry RankSector Rank
OM 14.05%
PM (TTM) 7.15%
GM 43.89%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
DIM.PA Yearly Profit, Operating, Gross MarginsDIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DIM is creating some value.
DIM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DIM has more shares outstanding
Compared to 1 year ago, DIM has an improved debt to assets ratio.
DIM.PA Yearly Shares OutstandingDIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DIM.PA Yearly Total Debt VS Total AssetsDIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 4.14 indicates that DIM is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.14, DIM is doing good in the industry, outperforming 75.00% of the companies in the same industry.
The Debt to FCF ratio of DIM is 5.03, which is a neutral value as it means it would take DIM, 5.03 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.03, DIM is in line with its industry, outperforming 50.00% of the companies in the same industry.
DIM has a Debt/Equity ratio of 0.72. This is a neutral value indicating DIM is somewhat dependend on debt financing.
DIM's Debt to Equity ratio of 0.72 is on the low side compared to the rest of the industry. DIM is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 5.03
Altman-Z 4.14
ROIC/WACC0.52
WACC8.36%
DIM.PA Yearly LT Debt VS Equity VS FCFDIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.85 indicates that DIM should not have too much problems paying its short term obligations.
DIM has a better Current ratio (1.85) than 81.25% of its industry peers.
A Quick Ratio of 1.14 indicates that DIM should not have too much problems paying its short term obligations.
DIM's Quick ratio of 1.14 is fine compared to the rest of the industry. DIM outperforms 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.14
DIM.PA Yearly Current Assets VS Current LiabilitesDIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.97% over the past year.
The Earnings Per Share has been growing slightly by 4.19% on average over the past years.
The Revenue has been growing slightly by 5.21% in the past year.
DIM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.05% yearly.
EPS 1Y (TTM)4.97%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%34.88%
Revenue 1Y (TTM)5.21%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%11.65%

3.2 Future

DIM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.34% yearly.
Based on estimates for the next years, DIM will show a quite strong growth in Revenue. The Revenue will grow by 9.61% on average per year.
EPS Next Y23.98%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
EPS Next 5Y19.34%
Revenue Next Year8.6%
Revenue Next 2Y9.87%
Revenue Next 3Y10.54%
Revenue Next 5Y9.61%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DIM.PA Yearly Revenue VS EstimatesDIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
DIM.PA Yearly EPS VS EstimatesDIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 55.95, DIM can be considered very expensive at the moment.
81.25% of the companies in the same industry are cheaper than DIM, based on the Price/Earnings ratio.
DIM is valuated expensively when we compare the Price/Earnings ratio to 28.18, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 38.56, which means the current valuation is very expensive for DIM.
Based on the Price/Forward Earnings ratio, DIM is valued expensively inside the industry as 81.25% of the companies are valued cheaper.
The average S&P500 Price/Forward Earnings ratio is at 20.81. DIM is valued rather expensively when compared to this.
Industry RankSector Rank
PE 55.95
Fwd PE 38.56
DIM.PA Price Earnings VS Forward Price EarningsDIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DIM is valued more expensive than 81.25% of the companies in the same industry.
DIM's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. DIM is more expensive than 68.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 35.46
EV/EBITDA 32.06
DIM.PA Per share dataDIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
DIM's earnings are expected to grow with 24.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.33
PEG (5Y)13.34
EPS Next 2Y25.51%
EPS Next 3Y24.81%

More info and screens

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.33%, DIM is not a good candidate for dividend investing.
DIM's Dividend Yield is slightly below the industry average, which is at 0.82.
Compared to an average S&P500 Dividend Yield of 2.45, DIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.33%

5.2 History

The dividend of DIM has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years2
Div Non Decr Years2
DIM.PA Yearly Dividends per shareDIM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

32.84% of the earnings are spent on dividend by DIM. This is a low number and sustainable payout ratio.
DIM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP32.84%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
DIM.PA Yearly Income VS Free CF VS DividendDIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
DIM.PA Dividend Payout.DIM.PA Dividend Payout, showing the Payout Ratio.DIM.PA Dividend Payout.PayoutRetained Earnings

More info and screens

SARTORIUS STEDIM BIOTECH

EPA:DIM (5/5/2025, 12:09:23 PM)

212.6

+1.1 (+0.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)04-16 2025-04-16/bmo
Earnings (Next)07-22 2025-07-22
Inst Owners11.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.69B
Analysts78.89
Price Target252.73 (18.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.33%
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP32.84%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.91%
Min EPS beat(2)7.63%
Max EPS beat(2)22.18%
EPS beat(4)2
Avg EPS beat(4)0.98%
Min EPS beat(4)-20.27%
Max EPS beat(4)22.18%
EPS beat(8)2
Avg EPS beat(8)-16.9%
EPS beat(12)2
Avg EPS beat(12)-16.88%
EPS beat(16)5
Avg EPS beat(16)-11.85%
Revenue beat(2)2
Avg Revenue beat(2)3.21%
Min Revenue beat(2)2.91%
Max Revenue beat(2)3.52%
Revenue beat(4)3
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)3.52%
Revenue beat(8)4
Avg Revenue beat(8)-1.35%
Revenue beat(12)4
Avg Revenue beat(12)-1.7%
Revenue beat(16)8
Avg Revenue beat(16)12.23%
PT rev (1m)-1.8%
PT rev (3m)12.39%
EPS NQ rev (1m)-1.38%
EPS NQ rev (3m)0.4%
EPS NY rev (1m)-0.49%
EPS NY rev (3m)1.23%
Revenue NQ rev (1m)-3.7%
Revenue NQ rev (3m)-1.81%
Revenue NY rev (1m)-0.95%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 55.95
Fwd PE 38.56
P/S 7.24
P/FCF 35.46
P/OCF 23.53
P/B 5.21
P/tB N/A
EV/EBITDA 32.06
EPS(TTM)3.8
EY1.79%
EPS(NY)5.51
Fwd EY2.59%
FCF(TTM)6
FCFY2.82%
OCF(TTM)9.04
OCFY4.25%
SpS29.36
BVpS40.81
TBVpS-5.43
PEG (NY)2.33
PEG (5Y)13.34
Profitability
Industry RankSector Rank
ROA 2.46%
ROE 5.14%
ROCE 5.47%
ROIC 4.36%
ROICexc 4.84%
ROICexgc 15.14%
OM 14.05%
PM (TTM) 7.15%
GM 43.89%
FCFM 20.42%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexcg growth 3Y-36.77%
ROICexcg growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score7
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 5.03
Debt/EBITDA 4
Cap/Depr 95.85%
Cap/Sales 10.35%
Interest Coverage 2.25
Cash Conversion 123.84%
Profit Quality 285.66%
Current Ratio 1.85
Quick Ratio 1.14
Altman-Z 4.14
F-Score7
WACC8.36%
ROIC/WACC0.52
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)4.97%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%34.88%
EPS Next Y23.98%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
EPS Next 5Y19.34%
Revenue 1Y (TTM)5.21%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%11.65%
Revenue Next Year8.6%
Revenue Next 2Y9.87%
Revenue Next 3Y10.54%
Revenue Next 5Y9.61%
EBIT growth 1Y-0.84%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year85.65%
EBIT Next 3Y36.02%
EBIT Next 5Y24.38%
FCF growth 1Y325.99%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y45.08%
OCF growth 3Y5.11%
OCF growth 5Y21.32%